• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo
* * * * * 1 votes

NAD Boosters fail in new lifespan trial

nad nmn nad+ lifespan nia itp

  • This topic is locked This topic is locked
30 replies to this topic

#31 Jesus Evola

  • Registrant
  • 8 posts
  • 7
  • Location:Minnesota

Posted 07 February 2023 - 10:14 PM

It's probably all degraded to NAM no matter what the dose. But that doesn't matter as NAM raises NAD+ very nicely. Any perceived advantage of NR over NAM (or NAM+R, especially) is purely marketing. A second problem is daily use. This will suppress mito mass and result in lower ATP output. NR or NAM+R should thus be used intermittently, and/or with PQQ.

 

We found a clear advantage of several ratios of NAM+R over NR, with a 1:4.5 ratio of NAM to R respectively, producing a 26.5% advantage in NAD production in an animal model.  An equimolar comparision is unquestionably in favor of NAM+R.    


  • Informative x 2





Also tagged with one or more of these keywords: nad, nmn, nad+, lifespan, nia, itp

3 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users


    Facebook (2)